Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.
2.

Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.

Pasquino AM, Pucarelli I, Roggini M, Segni M.

J Clin Endocrinol Metab. 2000 Feb;85(2):619-22.

PMID:
10690865
3.

[Effects of gonadotropin releasing hormone analog and growth hormone on height in girls with idiopathic central precocious puberty].

Wang CL, Liang L, Liu PN, Jin XJ, Chen LQ, Yang F, Lian Q, Chen RM.

Zhongguo Dang Dai Er Ke Za Zhi. 2014 Jan;16(1):25-30. Chinese.

PMID:
24461173
4.

Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty.

Pasquino AM, Municchi G, Pucarelli I, Segni M, Mancini MA, Troiani S.

J Clin Endocrinol Metab. 1996 Mar;81(3):948-51.

PMID:
8772556
5.

Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.

Pasquino AM, Pucarelli I, Segni M, Matrunola M, Cerroni F.

J Clin Endocrinol Metab. 1999 Feb;84(2):449-52. Erratum in: J Clin Endocrinol Metab 1999 Jun;84(6):1978. Cerrone F [corrected to Cerroni F].

PMID:
10022399
6.

Combined therapy with GnRH analog plus growth hormone in central precocious puberty.

Pucarelli I, Segni M, Ortore M, Moretti A, Iannaccone R, Pasquino AM.

J Pediatr Endocrinol Metab. 2000 Jul;13 Suppl 1:811-20.

PMID:
10969926
8.

Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.

Poomthavorn P, Suphasit R, Mahachoklertwattana P.

Gynecol Endocrinol. 2011 Aug;27(8):524-8. doi: 10.3109/09513590.2010.507289. Epub 2011 Apr 18.

PMID:
21501002
9.

Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution.

Pucarelli I, Segni M, Ortore M, Arcadi E, Pasquino AM.

J Pediatr Endocrinol Metab. 2003 Sep;16(7):1005-10.

PMID:
14513877
10.

Effect of GnRHa 3.75 mg subcutaneously every 6 weeks on adult height in girls with idiopathic central precocious puberty.

Liang Y, Wei H, Li J, Hou L, Zhang J, Wu W, Ying Y, Luo X.

J Pediatr Endocrinol Metab. 2015 Jul;28(7-8):839-46. doi: 10.1515/jpem-2014-0305.

PMID:
25719299
11.
12.
13.

The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study.

Magiakou MA, Manousaki D, Papadaki M, Hadjidakis D, Levidou G, Vakaki M, Papaefstathiou A, Lalioti N, Kanaka-Gantenbein C, Piaditis G, Chrousos GP, Dacou-Voutetakis C.

J Clin Endocrinol Metab. 2010 Jan;95(1):109-17. doi: 10.1210/jc.2009-0793. Epub 2009 Nov 6.

PMID:
19897682
15.
16.

[Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].

Ságodi L, Sólyom E, Lombay B, Almási A, Vámosi I.

Orv Hetil. 2012 Mar 18;153(11):418-24. doi: 10.1556/OH.2012.29320. Hungarian.

PMID:
22390866
17.

[Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].

Chen SK, Fan X, Tang Q.

Zhongguo Dang Dai Er Ke Za Zhi. 2009 May;11(5):374-6. Chinese.

PMID:
19470261
18.

Gonadotrophin releasing hormone agonist treatment with or without recombinant human GH in adopted children with early puberty.

Mul D, Oostdijk W, Waelkens JJ, Schulpen TW, Drop SL.

Clin Endocrinol (Oxf). 2001 Jul;55(1):121-9.

PMID:
11453961
19.

Supplemental Content

Support Center